China IPR SME HelpDesk Webinar: Differences between IP Protection in China vs. Europe – 3 September 2014
September 1, 2014 Category Activities, Weekly
Space is limited. Reserve your Webinar seat now at: https://www3.gotomeeting.com/register/975842750
There are several key differences between Chinese and European IP laws which are important to understand in order to efficiently manage your intellectual property in China. The Expert`s presentation will highlight the differences between Intellectual Property Protection in China vs. Europe for European SMEs looking to do business in China and the main points to watch out for. Primarily the focus will be on the IP issues most relevant to European SMEs including (but not limited to):
Different type of rights
Different types of registration and what that means for EU SMEs
Main tips to look out for before doing business in China
This free, 45-minute webinar presentation and 30 minute Q&A session on Wednesday, 3 September 2014 at 10:30 am Brussels time (9:30 am London, 4:30 pm China) will take you through a range of simple, cost-effective measures to protect your intellectual property and your business in China. Get valuable insights from our expert, and ask questions live throughout the webinar.
Please see our short 2-page Quick Start guide for more information on Helpdesk webinars, how they can help your business, and the simple registration process. This webinar and associated materials will be in English.
Title: Differences between IP Protection in China vs. Europe
Date: Wednesday, 3 September 2014 Time: 10:30 AM – 11:45 AM CET
After registering you will receive a confirmation email containing information about joining the Webinar.
System Requirements: PC-based attendees Required: Windows 7, Vista, XP or 2003 Server
Macintosh-based attendees Required: Mac OS X 10.5 or newer
- KURT VANDEPUTTE (UMICORE) APPOINTED CHAIRMAN OF THE BOARD OF THE FLANDERS-CHINA CHAMBER OF COMMERCE (FCCC)
- Webinar: “Knowing Your Chinese Partner” – May 26, 2021, 10 am – 12 am
- EMA starts rolling review of CoronaVac, WHO approves Sinopharm vaccine for emergency use
- The Global Times warns not to politicize the Comprehensive Agreement on Investment (CAI)
- Hainan to become biggest duty-free market in the world